John Taylor

President; Principal of Regulatory Compliance
Greenleaf Health, Inc.
 

John Taylor joined Greenleaf following a distinguished career of more than 20 years at the Food and Drug Administration (FDA). During his time at the agency, he led several of its priority initiatives. At Greenleaf, Mr. Taylor continues his commitment to healthcare innovation as the firm’s president and principal of compliance & regulatory affairs, providing strategic consultation to FDA-regulated clients on enforcement and compliance matters.

From 2009–2014, Mr. Taylor held three high-profile positions at FDA: counselor to the commissioner, acting deputy principal commissioner and acting deputy commissioner for global regulatory operations and policy. As counselor to the commissioner, he served as the principal advisor to commissioner Margaret Hamburg on issues that affected the agency’s programs, policymaking, management, budget, and administration. In his role as Acting Deputy Commissioner for Global Regulatory Operations and Policy, Mr. Taylor provided leadership and direction to more than 4,000 employees in FDA’s Office of Regulatory Affairs and Office of International Programs.

Mr. Taylor began as an attorney within FDA’s Office of the Chief Counsel in 1991. During this time, he was responsible for all phases of criminal and civil litigation related to violations of the Federal Food, Drug, and Cosmetic Act and other federal laws. In 1997, Mr. Taylor was promoted to senior advisor for regulatory operations and policy within FDA’s Office of the Commissioner. He was later named Director of the Center for Drug Evaluation and Research’s Office of Compliance. In 2000, he accepted the position of director of ORA’s Office of Enforcement. Two years later, he was promoted to associate commissioner for regulatory affairs.

 

Sessions: 

Panel Discussion: The 10 Best — and 10 Worst — Things to Do When FDA Staff Are on Site